Target Price | $30.60 |
Price | $23.28 |
Potential |
31.44%
register free of charge
|
Number of Estimates | 23 |
23 Analysts have issued a price target Privia Health Group 2026 .
The average Privia Health Group target price is $30.60.
This is
31.44%
register free of charge
$38.85
66.88%
register free of charge
$21.21
8.89%
register free of charge
|
|
A rating was issued by 28 analysts: 25 Analysts recommend Privia Health Group to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2026 of
31.44%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 1.74 | 3.40 |
4.74% | 95.64% | |
EBITDA Margin | 1.40% | 3.28% |
14.82% | 134.86% | |
Net Margin | 0.83% | 0.60% |
40.48% | 27.60% |
24 Analysts have issued a sales forecast Privia Health Group 2025 . The average Privia Health Group sales estimate is
This results in the following potential growth metrics:
24 Analysts have issued an Privia Health Group EBITDA forecast 2025. The average Privia Health Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Privia Health Group Analysts have issued a net profit forecast 2025. The average Privia Health Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.11 | 0.17 |
42.11% | 54.55% | |
P/E | 141.07 | |
EV/Sales | 0.73 |
24 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group EPS is
This results in the following potential growth metrics and future valuations:
Privia Health Group...
Analyst | Rating | Action | Date |
---|---|---|---|
Stephens & Co. |
Locked
➜
Locked
|
Locked | Sep 04 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Aug 29 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | May 28 2025 |
Barclays |
Locked
➜
Locked
|
Locked | May 27 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
Analyst Rating | Date |
---|---|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Sep 04 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Aug 29 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 11 2025 |
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 09 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
May 28 2025 |
Locked
Barclays:
Locked
➜
Locked
|
May 27 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Apr 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.